Abstract PR003: DHX9 inhibition as a novel therapeutic for ovarian and breast cancer with loss-of-function mutations in the DNA damage repair genes BRCA1 or BRCA2
Castro, Jennifer, Daniels, Matthew H., Pai, Sunaina, Laidlaw, Monique, Wu, Jie, Brennan, David, Johnston, Brian T., Raman, Anugraha, Lu, Chuang, Blakemore, Stephen J., Silver, Serena J., Boriack-Sjodin, P. Ann, Duncan, Kenneth W., Sager, Jason A., Copeland, Robert A.
Published in Cancer research (Chicago, Ill.) (09.01.2024)
Published in Cancer research (Chicago, Ill.) (09.01.2024)
Get full text
Journal Article
Abstract SY11-02: Small molecule inhibitors of RNA modifying enzymes as precision cancer therapeutics
Copeland, Robert A., Castro, Jennifer, Daniels, Matthew H., Gotur, Deepali, Lee, Young-Tae, Yao, Shihua, Brennan, David, Johnston, Brian T., Laidlaw, Monique, Pai, Sunaina, Wu, Jie, Bansal, Rishabh, Raman, Anugraha, Buker, Shane M., Liu, Julie, Sickmier, E. Allen, Knockenhauer, Kevin, Lu, Chuang, Blakemore, Stephen J., Silver, Serena J., Boriack-Sjodin, P. Ann, Duncan, Kenneth W., Sager, Jason A.
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article